Harbor Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Harbor Investment Advisory's BMY Position: Q2 2026 in Review
Harbor Investment Advisory reduced its Bristol-Myers Squibb (BMY) stake by 0.59% in Q2 2026, selling an estimated $2.87K and leaving 8,368 shares worth $482K. The position accounts for 0.03% of the portfolio, ranked #300.
Harbor Investment Advisory first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.35M in Q1 2021. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Harbor Investment Advisory held 8,368 shares of Bristol-Myers Squibb worth $482K as of Q2 2026.
- Harbor Investment Advisory sold 50 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.87K.
- Bristol-Myers Squibb made up 0.03% of Harbor Investment Advisory's portfolio in Q2 2026, its #300 holding.
- Harbor Investment Advisory first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
- Harbor Investment Advisory's Bristol-Myers Squibb position peaked at $2.35M in Q1 2021.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.